Search

everythinglearnresearchcommunity

for

Search:↓

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

White hairs often regrow in alopecia areata patches.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Adolescents with severe alopecia incur significantly higher healthcare costs.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Stem cells could improve hair growth and new treatments for baldness are being researched.

Vitiligo causes white skin patches and can lead to psychological stress.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.